Raymond James Financial »

Palvella Therapeutics Inc Ne shares owned by Raymond James Financial

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.5M 24k 62.60
2025-06-30 $113 5 22.60

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Palvella Therapeutics Inc Ne

BVF
Suvretta Capital Management
Frazier Life Sciences Management
First Light Asset Management
Vanguard Group
BlackRock
Perceptive Advisors
Woodline Partners
Federated Investors
Point72 Asset Management
Nantahala Capital Management
Goldman Sachs Group
Samsara BioCapital
Fred Alger Management
Geode Capital Management

View all funds holding Palvella Therapeutics Inc Ne